Presentation is loading. Please wait.

Presentation is loading. Please wait.

Reproducibility and Changes in Vena Caval Blood Flow by Using Four-dimensional Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease:

Published byRikke Winther Modified over 5 years ago

Similar presentations

Presentation on theme: "Reproducibility and Changes in Vena Caval Blood Flow by Using Four-dimensional Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease:"— Presentation transcript:

1 Reproducibility and Changes in Vena Caval Blood Flow by Using Four-dimensional Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease: The MESA Chronic Obstructive Pulmonary Disease Substudy Four-dimensional (4D) flow MRI helps to provide a comprehensive assessment of right heart hemodynamics with good-to-excellent reproducibility in healthy participants and participants with chronic obstructive pulmonary disease (COPD) and emphysema. Right heart 4D flow MRI allows for the detection of differences in blood flow dynamics in participants with COPD and in control populations. Emphysema was associated with elevated right heart regurgitant flow, potentially related to higher pulmonary vascular resistance. Rahman O et al. Published Online: July 23, 2019

Download ppt "Reproducibility and Changes in Vena Caval Blood Flow by Using Four-dimensional Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease:"

Similar presentations

Carbon monoxide and nitrogen dioxide in the atmosphere: A look at the effects on chronic obstructive pulmonary disease Carbon monoxide and nitrogen dioxide.

Carbon monoxide and nitrogen dioxide in the atmosphere: A look at the effects on chronic obstructive pulmonary disease Carbon monoxide and nitrogen dioxide.
Long Term Effects Of Tobacco Use TSWBBAT Describe how tobacco use affects the body systems -short term and long term.

Long Term Effects Of Tobacco Use TSWBBAT Describe how tobacco use affects the body systems -short term and long term.
Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease Respiration 2011;81:196–205.

Differences in Response to Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease Respiration 2011;81:196–205.
Chronic obstructive pulmonary disease (COPD)

Chronic obstructive pulmonary disease (COPD)
Flow diagram of participants included in the survey. aResponse rate

Flow diagram of participants included in the survey. aResponse rate
Meghan E. Sise, Andrew M. Courtwright, Richard N. Channick 

Meghan E. Sise, Andrew M. Courtwright, Richard N. Channick 
Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.

Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.
Ventilatory and cerebrovascular responses to hyperoxic hypercapnia.

Ventilatory and cerebrovascular responses to hyperoxic hypercapnia.
Relationship between the change in a) ventilatory and b) cerebrovascular responses in older healthy subjects (Older) and chronic obstructive pulmonary.

Relationship between the change in a) ventilatory and b) cerebrovascular responses in older healthy subjects (Older) and chronic obstructive pulmonary.
Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.

Patients with exacerbations of chronic obstructive pulmonary disease admitted to hospital according to the day of the week (A), and presenting to the emergency.
Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.

Distribution of lower extremity artery disease (LEAD) Fontaine stages over the combined chronic obstructive pulmonary disease (COPD) Global Initiative.
Monthly admissions for chronic obstructive pulmonary disease (COPD) to Christchurch Hospital. Monthly admissions for chronic obstructive pulmonary disease.

Monthly admissions for chronic obstructive pulmonary disease (COPD) to Christchurch Hospital. Monthly admissions for chronic obstructive pulmonary disease.
The top 25 analytes by relevant q-value differentially expressed in HIV with COPD. The top number is m/z and the bottom number is RT. Y-axis is intensity.

The top 25 analytes by relevant q-value differentially expressed in HIV with COPD. The top number is m/z and the bottom number is RT. Y-axis is intensity.
Conceptual framework of the interaction between environmental exposure including smoking, alpha-1 antitrypsin (AAT) level and/or AAT genotype, other genetic.

Conceptual framework of the interaction between environmental exposure including smoking, alpha-1 antitrypsin (AAT) level and/or AAT genotype, other genetic.
Venn diagram showing the overlap between the various chronic obstructive pulmonary disease (COPD) diagnoses: self-reported physician-diagnosed, fixed ratio.

Venn diagram showing the overlap between the various chronic obstructive pulmonary disease (COPD) diagnoses: self-reported physician-diagnosed, fixed ratio.
Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT Coronary microvascular.

Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT Coronary microvascular.
Use of Elastic Registration in Pulmonary MRI for the Assessment of Pulmonary Fibrosis in Patients with Systemic Sclerosis Areas of marked lung shrinkage.

Use of Elastic Registration in Pulmonary MRI for the Assessment of Pulmonary Fibrosis in Patients with Systemic Sclerosis Areas of marked lung shrinkage.
Comparison of the age-associated prevalence (y axis) in the Catalan Healthcare Surveillance System (CHSS) and Medicare datasets of selected disease groups.

Comparison of the age-associated prevalence (y axis) in the Catalan Healthcare Surveillance System (CHSS) and Medicare datasets of selected disease groups.
Example action effect diagram for a chronic obstructive pulmonary disease improvement initiative constructed retrospectively at the end of the initiative.

Example action effect diagram for a chronic obstructive pulmonary disease improvement initiative constructed retrospectively at the end of the initiative.
In 507 follow-up images, only 1

In 507 follow-up images, only 1

Similar presentations

Ads by Google